Clinical Trial Update: The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria [NA]

View source ↗

Summary

This clinical trial update describes a study comparing the combination of dulaglutide and dapagliflozin to DPP-4 inhibitors in adults with type 2 diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitors
• FARXIGA (dapagliflozin)
• TRULICITY (DULAGLUTIDE)

Snippet

Sponsor: Attikon Hospital | Conditions: Urine Albumin (UAlb), Glycocalyx | NA | Status: ACTIVE_NOT_RECRUITING